Table 3.
Cause of discontinuation | Number of cases/events |
---|---|
Lack of efficacy | 12 cases (5.2%) |
Adverse events | 26 cases (11.4%) |
Pneumonia | 6 |
Heart failure | 3 |
Worsening comorbidity | 3 |
Liver damage | 2 |
Interstitial pneumonia | 2 |
Skin ulcer | 2 |
Cerebellar hemorrhage | 2 |
Anaphylaxis | 1 |
Chest pain | 1 |
Myocardial infarction | 1 |
Leukopenia | 1 |
Breast cancer | 1 |
Phlegmon | 1 |
Miscellaneous | 9 cases (3.9%) |
Unknown | 4 |
Moving | 3 |
Patient’s will | 2 |
Total | 47 cases (20.5%) |